Viewing Study NCT01381757

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:31 PM
Ignite Modification Date: 2025-12-30 @ 1:50 AM
Study NCT ID: NCT01381757
Status: TERMINATED
Last Update Posted: 2018-04-05
First Post: 2011-06-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Tuberculosis, Pulmonary View
None Mycobacterium Tuberculous View
None Antitubercular Agents View
None Tuberculosis, Mulutidrug-Resistant View
None Extensively Drug-Resistant View
None Extensibely Drug-Resistant Tuberculosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Extensively Drug-Resistant Tuberculosis View
None First-Line Antituberculous Drugs View
None Second-Line Antituberculous Drugs View
None Middlebrook Culture View
None Agar Proportion Method View